In this study, it was concluded that in the evaluation of Her-2 in uterine carcinosarcoma, the lateral/basolateral staining pattern gave more accurate results instead of the complete membranous staining pattern, and therefore it would be more appropriate to perform the evaluation according to gastric cancer criteria rather than breast cancer criteria. This evidence concerns the gene ERBB2 and breast carcinoma.